3.61
4.50%
-0.17
Dopo l'orario di chiusura:
3.61
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PYXS Giù?
Forum
Previsione
Precedente Chiudi:
$3.78
Aprire:
$3.79
Volume 24 ore:
387.68K
Relative Volume:
0.69
Capitalizzazione di mercato:
$222.80M
Reddito:
-
Utile/perdita netta:
$-73.79M
Rapporto P/E:
-1.2711
EPS:
-2.84
Flusso di cassa netto:
$-77.44M
1 W Prestazione:
+0.56%
1M Prestazione:
+7.44%
6M Prestazione:
-29.49%
1 anno Prestazione:
+71.09%
Pyxis Oncology Inc Stock (PYXS) Company Profile
Nome
Pyxis Oncology Inc
Settore
Industria
Telefono
(617) 221-9059
Indirizzo
321 HARRISON AVENUE, BOSTON
Pyxis Oncology Inc Stock (PYXS) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2021-11-02 | Iniziato | BofA Securities | Neutral |
2021-11-02 | Iniziato | Credit Suisse | Outperform |
2021-11-02 | Iniziato | Jefferies | Buy |
Pyxis Oncology Inc Borsa (PYXS) Ultime notizie
Moment Of Truth Approaches For Pyxis Oncology (NASDAQ:PYXS) - Seeking Alpha
Pyxis Oncology : Morgan Stanley 22nd Annual Global Healthcare Conference - Marketscreener.com
Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Pyxis Oncology Inc (PYXS) looking to reclaim success with recent performance - SETE News
Have you been able to find a good deal on Pyxis Oncology Inc’s shares? - US Post News
Quarterly Snapshot: Quick and Current Ratios for Pyxis Oncology Inc (PYXS) - The Dwinnex
Pyxis Oncology to Participate in Two Upcoming Investor Conferences - GlobeNewswire
Pyxis Oncology to Participate in Two Upcoming Investor Conferences - StockTitan
JAZZ: 3 Oncology Stocks With Major Upside - StockNews.com
PYXS Stock Earnings: Pyxis Oncology Misses EPS for Q2 2024 - MSN
Market Momentum Report: Pyxis Oncology Inc (PYXS)’s Positive Close at 3.62 - The Dwinnex
Q3 2024 EPS Estimates for Pyxis Oncology, Inc. Boosted by William Blair (NASDAQ:PYXS) - MarketBeat
What is the investor’s view on Pyxis Oncology Inc (PYXS)? - US Post News
Cetera Advisors LLC Makes New $100,000 Investment in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Q3 2024 Earnings Estimate for Pyxis Oncology, Inc. (NASDAQ:PYXS) Issued By William Blair - Defense World
Vanguard Group Inc. Acquires 94,740 Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Pyxis Oncology's (PYXS) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
Pyxis Oncology maintains steady target with Buy rating from H.C. Wainwright - Investing.com India
Pyxis Oncology maintains steady target with Buy rating from H.C. Wainwright - Investing.com
Market Insight: Pyxis Oncology Inc (PYXS)’s Notable Gain, Closing at 3.43 - The Dwinnex
Pyxis Oncology (NASDAQ:PYXS) Earns “Buy” Rating from HC Wainwright - Defense World
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024 - GlobeNewswire
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024 - Marketscreener.com
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024 - StockTitan
Analysts Set Pyxis Oncology, Inc. (NASDAQ:PYXS) PT at $9.00 - MarketBeat
Pyxis Oncology, Inc. (NASDAQ:PYXS) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Pyxis Oncology stock gains as Stifel says buy (NASDAQ:PYXS) - Seeking Alpha
Pyxis Oncology (NASDAQ:PYXS) Earns Buy Rating from Analysts at Stifel Nicolaus - MarketBeat
What was Pyxis Oncology Inc (PYXS)’s performance in the last session? - US Post News
Pyxis Oncology (NASDAQ:PYXS) Earns Buy Rating from Analysts at Stifel Nicolaus - Defense World
Stifel sets $10 target on Pyxis Oncology, cites unique approach - Investing.com
Market Recap Check: Pyxis Oncology Inc (PYXS)’s Positive Finish at 3.37, Up/Down 3.69 - The Dwinnex
Pyxis Oncology Insider Stock Sellers Must Be Relieved As Market Cap Falls To US$203m - Simply Wall St
Pyxis Oncology Inc (PYXS) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News
SG Americas Securities LLC Makes New Investment in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference - GlobeNewswire
Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference - Marketscreener.com
Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference - StockTitan
July Breakout: Healthcare Biotechs In The Strongest Move Since November - Seeking Alpha
Pyxis Oncology, Inc. (NASDAQ:PYXS) Short Interest Update - MarketBeat
RBC Capital remains positive on Pyxis Oncology stock - Investing.com
Is Pyxis Oncology Inc (PYXS) positioned for future growth? - SETE News
Was Pyxis Oncology Inc (PYXS)’s session last reading good? - US Post News
Pyxis Oncology Inc (PYXS) Stock: A Year of Market Fluctuations - The InvestChronicle
Pyxis Oncology Inc (PYXS) stock analysis: A comprehensive overview - US Post News
Susquehanna Fundamental Investments LLC Invests $351,000 in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World
Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives $8.80 Consensus Price Target from Analysts - MarketBeat
Did Pyxis Oncology Inc (PYXS) perform well in the last session? - US Post News
Analytical Overview: Pyxis Oncology Inc (PYXS)’s Ratios Tell a Financial Story - The Dwinnex
Nothing is Better Than Pyxis Oncology Inc (PYXS) stock at the moment - SETE News
Pyxis Oncology Inc Azioni (PYXS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Pyxis Oncology Inc Azioni (PYXS) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Wadhane Jitendra | Chief Accounting Officer |
Sep 27 '23 |
Buy |
1.87 |
2,500 |
4,675 |
226,937 |
Connealy Pamela Ann | CFO and COO |
Sep 27 '23 |
Buy |
1.85 |
6,426 |
11,868 |
810,532 |
Wadhane Jitendra | Chief Accounting Officer |
Sep 25 '23 |
Buy |
1.77 |
5,000 |
8,850 |
224,437 |
Connealy Pamela Ann | CFO and COO |
Sep 25 '23 |
Buy |
1.67 |
12,000 |
20,044 |
804,106 |
Wadhane Jitendra | Chief Accounting Officer |
Sep 22 '23 |
Buy |
1.74 |
2,500 |
4,349 |
219,437 |
Connealy Pamela Ann | CFO and COO |
Sep 22 '23 |
Buy |
1.74 |
5,000 |
8,695 |
792,106 |
Sullivan Lara | President and CEO |
Sep 18 '23 |
Sale |
2.10 |
8,541 |
17,936 |
2,403,882 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):